{"id":1121,"date":"2025-09-08T06:00:51","date_gmt":"2025-09-08T06:00:51","guid":{"rendered":"https:\/\/perfusfind.com\/ic\/?p=1121"},"modified":"2025-09-07T16:57:56","modified_gmt":"2025-09-07T16:57:56","slug":"respiratory-management-of-critically-ill-pneumocystis-pneumonia-patients-a-multicenter-retrospective-study","status":"publish","type":"post","link":"https:\/\/perfusfind.com\/ic\/index.php\/2025\/09\/08\/respiratory-management-of-critically-ill-pneumocystis-pneumonia-patients-a-multicenter-retrospective-study\/","title":{"rendered":"Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study"},"content":{"rendered":"

\ud83e\udec1 Respiratory Management of Critically Ill Pneumocystis Pneumonia Patients<\/h3>\n

Reizine F, Stiegler V, L\u00e9cuyer R, Tessoulin B, Gallais M, Camou F, Morio F, Cady A, Gabriel F, Canet E, Raffi F, Boutoille D, Issa N, Gaborit B, and the PRONOCYSTIS Study Group. Ann Intensive Care.<\/em> 2025;15:114. doi:10.1186\/s13613-025-01503-6<\/strong><\/p>\n

\n

Abstract:<\/strong><\/p>\n<\/blockquote>\n

Pneumocystis jirovecii pneumonia (PjP) is an emerging cause of acute respiratory failure (ARF) in immunocompromised patients. Using data from the multicenter PRONOCYSTIS cohort, this study evaluated outcomes associated with different respiratory strategies\u2014standard oxygen (SO), non-invasive ventilation (NIV), and high-flow nasal cannula (HFNC)\u2014in 248 ICU patients. The primary endpoint was intubation rate, with survival analyzed using Cox regression and propensity score methods.<\/p>\n

\n
\n
\n
\n
Minimize image<\/div>\n
Edit image<\/div>\n
Delete image<\/div>\n<\/div>\n<\/div>\n

\"\"<\/div>